Lexicon: 2Q Earnings Snapshot

July 30, 2018

THE WOODLANDS, Texas (AP) _ Lexicon Pharmaceuticals Inc. (LXRX) on Monday reported a loss of $34.7 million in its second quarter.

On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 33 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share.

The drugmaker posted revenue of $13.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $16.6 million.

Lexicon shares have increased 25 percent since the beginning of the year. The stock has decreased 25 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LXRX at https://www.zacks.com/ap/LXRX

Update hourly